Morten Herholdt
Stock Analyst at HSBC
(3.21)
# 2,426
Out of 4,444 analysts
32
Total ratings
69.6%
Success rate
8.4%
Average return
Main Sectors:
Stocks Rated by Morten Herholdt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BIIB Biogen | Maintained: Sell | $143 → $150 | $199.59 | -24.85% | 6 | Mar 17, 2026 | |
| JNJ Johnson & Johnson | Maintained: Buy | $240 → $280 | $241.00 | +16.18% | 8 | Mar 17, 2026 | |
| AMGN Amgen | Maintained: Buy | $425 | $351.43 | +20.93% | 5 | Dec 10, 2025 | |
| GILD Gilead Sciences | Maintained: Hold | $133 | $125.16 | +6.26% | 5 | Dec 10, 2025 | |
| ZTS Zoetis | Maintained: Buy | $230 | $78.17 | n/a | 2 | Feb 19, 2024 | |
| UNH UnitedHealth Group | Downgraded: Sell | $540 → $480 | $405.80 | n/a | 2 | Dec 18, 2023 | |
| LH Labcorp Holdings | Initiated Coverage: Hold | $210 | $265.18 | n/a | 1 | Sep 6, 2023 | |
| IQV IQVIA Holdings | Initiated Coverage: Buy | $260 | $185.62 | n/a | 1 | Sep 6, 2023 | |
| ATNM Actinium Pharmaceuticals | Initiated Coverage: Buy | $12 | $1.01 | n/a | 1 | Sep 6, 2023 | |
| LIVN LivaNova | Initiated Coverage: Hold | $52 | $79.95 | n/a | 1 | Sep 6, 2023 |
Biogen
Mar 17, 2026
Maintained: Sell
Price Target: $143 → $150
Current: $199.59
Upside: -24.85%
Johnson & Johnson
Mar 17, 2026
Maintained: Buy
Price Target: $240 → $280
Current: $241.00
Upside: +16.18%
Amgen
Dec 10, 2025
Maintained: Buy
Price Target: $425
Current: $351.43
Upside: +20.93%
Gilead Sciences
Dec 10, 2025
Maintained: Hold
Price Target: $133
Current: $125.16
Upside: +6.26%
Zoetis
Feb 19, 2024
Maintained: Buy
Price Target: $230
Current: $78.17
Upside: n/a
UnitedHealth Group
Dec 18, 2023
Downgraded: Sell
Price Target: $540 → $480
Current: $405.80
Upside: n/a
Labcorp Holdings
Sep 6, 2023
Initiated Coverage: Hold
Price Target: $210
Current: $265.18
Upside: n/a
IQVIA Holdings
Sep 6, 2023
Initiated Coverage: Buy
Price Target: $260
Current: $185.62
Upside: n/a
Actinium Pharmaceuticals
Sep 6, 2023
Initiated Coverage: Buy
Price Target: $12
Current: $1.01
Upside: n/a
LivaNova
Sep 6, 2023
Initiated Coverage: Hold
Price Target: $52
Current: $79.95
Upside: n/a